Table 1.
Relationship between TP73‐AS1 expression and clinicopathological features of breast cancer patients. The patients were divided into TP73‐AS1 high expression group (n = 25) and low expression group (n = 20) according to mean. High TP73‐AS1 expression was associated with distant metastasis
| Clinicopathological features | n | TP73‐AS1 expression | P‐value | |
|---|---|---|---|---|
| High (n = 25) | Low (n = 20) | |||
| ER status | ‐ | ‐ | ‐ | ‐ |
| Negative | 24 | 16 | 9 | 0.109 |
| Positive | 21 | 9 | 11 | ‐ |
| PR status | ‐ | ‐ | ‐ | ‐ |
| Negative | 23 | 10 | 13 | 0.095 |
| Positive | 22 | 15 | 7 | ‐ |
| HER2 status | ‐ | ‐ | ‐ | ‐ |
| Negative | 25 | 14 | 11 | 0.947 |
| Positive | 20 | 11 | 9 | ‐ |
| Distant metastasis | ‐ | ‐ | ‐ | ‐ |
| Yes | 27 | 20 | 7 | 0.002* |
| No | 18 | 5 | 13 | ‐ |
*
Means the significant difference.
ER, estrogen receptor α; HER2, human epidermal growth factor receptor 2; PR, progesterone receptor.